Team Elysium Completes Pre-Series A Round, Expands Digital Musculoskeletal Solutions
Reading Time: 2 minutesTeam Elysium, a Korea-based developer of digital musculoskeletal diagnostic and treatment solutions, has successfully completed its pre-SeriesA funding round.
This round included participation from existing investors Strong Ventures and Digital Healthcare Partners(DHP), along with new investors Evergreen Investment Partners and JIRAN PARTNERS.
Team Elysium plans to accelerate the expansion of its business model, which targets not only medical institutions but also non-medical entities such as fitness centers and corporations. This strategy aims to grow its revenue stream from musculoskeletal diagnostic solutions.
The company is dedicated to continuously developing innovative musculoskeletal analysis technologies, replacing traditional tools in clinical settings. This initiative has led to more than 300 medical institutions adopting Team Elysium’s products.
Moreover, Team Elysium has been making significant strides in the B2G sector. Following the launch of a program last year to manage physical imbalances in teenagers, it has since provided diagnostic tests and customized management programs for body imbalances to all fourth-grade students in the Jeollabuk-do region.
An Daegun, CEO of JIRAN PARTNERS, a participant in the additional multi-closing, remarked, “We have recognized the high growth potential in Team Elysium’s business expansion strategy, underpinned by its unique technological capabilities. With this investment, JIRAN PARTNERS is committed to actively supporting Team Elysium in becoming a leading company in both the domestic and international digital musculoskeletal diagnostic and treatment markets.”
Wonjin Kim, CEO of Team Elysium, stated, “Our persistent efforts to address the real-world challenges associated with musculoskeletal disorders are yielding results, as evidenced by our consistent sales growth. This pre-Series A funding will enable us not only to dominate the domestic musculoskeletal market but also to enhance our competitiveness in global markets.”
[Korean bioHealth Startups News]
- Dreampac Secures Funding to Develop PIPAC for Treating Peritoneal Carcinomatosis
- Rexpharm Forms MOU with Timely Basket to Develop and Distribute Health Foods in U.S.
- SEOUL BIOHUB Global Center Opens, Aiming to Boost Global BioTech Competitiveness
- Delight Room Invests in Soundable Health for Advanced Sound Analysis in Healthcare
- Apollon Secures 2.3 Billion KRW in Funding for Innovative Needle-Free CGM Technology
- Korean Space Medicine Startup SpaceLiintech Lands 4 Billion KRW Series A Funding
- ArtBlood Secures KRW 6.5 Billion in Series A for Synthetic Blood Production
- GLOUD Raises 3B KRW in Pre-Series A for Global Dental Digital Transformation Expansion
- Protium Science and HK innoN Forge Strategic Investment & Partnership
- LabInCube Raises KRW 5.1B in Series A for MOF Material Development
[Korean Startup Weekly News #3] AI Semiconductor Startup Rebellions Raises $140M in Series B Funding – 와우테일(WOWTALE)
[…] Team Elysium Completes Pre-Series A Round, Expands Digital Musculoskeletal SolutionsKorea-based Team Elysium completes its pre-SeriesA funding, expanding in digital musculoskeletal solutions with plans to grow in medical and non-medical sectors and B2G market initiatives. […]